Cannabix Technologies Inc. (BLOZF)
USD 0.41
(-5.16%)
USD 0.41
(-5.16%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 248.02 Thousand CAD | 4.58% |
| 2023 | 237.16 Thousand CAD | 96.27% |
| 2022 | 120.83 Thousand CAD | 49.6% |
| 2021 | 80.77 Thousand CAD | -12.41% |
| 2020 | 92.22 Thousand CAD | -56.78% |
| 2019 | 213.36 Thousand CAD | 14.27% |
| 2018 | 186.71 Thousand CAD | 17.84% |
| 2017 | 158.45 Thousand CAD | 2895.39% |
| 2016 | 5290.00 CAD | -92.4% |
| 2015 | 69.59 Thousand CAD | -14.81% |
| 2014 | 81.69 Thousand CAD | 131.74% |
| 2013 | 35.25 Thousand CAD | 1858.39% |
| 2012 | 1800.00 CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 194.01 Thousand CAD | -11.67% |
| 2024 FY | 248.02 Thousand CAD | 4.58% |
| 2024 Q3 | 107.02 Thousand CAD | -44.84% |
| 2024 Q4 | 248.02 Thousand CAD | 131.75% |
| 2024 Q1 | 219.64 Thousand CAD | -7.39% |
| 2023 Q3 | 138.42 Thousand CAD | 10.07% |
| 2023 Q4 | 237.16 Thousand CAD | 71.33% |
| 2023 FY | 237.16 Thousand CAD | 96.27% |
| 2023 Q1 | 149.35 Thousand CAD | 23.6% |
| 2023 Q2 | 125.76 Thousand CAD | -15.8% |
| 2022 Q2 | 109.63 Thousand CAD | 7.09% |
| 2022 Q1 | 102.38 Thousand CAD | 26.75% |
| 2022 FY | 120.83 Thousand CAD | 49.6% |
| 2022 Q4 | 120.83 Thousand CAD | 19.69% |
| 2022 Q3 | 100.95 Thousand CAD | -7.92% |
| 2021 Q3 | 92.79 Thousand CAD | -2.42% |
| 2021 Q2 | 95.09 Thousand CAD | 49.53% |
| 2021 Q1 | 63.59 Thousand CAD | -31.04% |
| 2021 FY | 80.77 Thousand CAD | -12.41% |
| 2021 Q4 | 80.77 Thousand CAD | -12.95% |
| 2020 Q1 | 87.32 Thousand CAD | -59.07% |
| 2020 FY | 92.22 Thousand CAD | -56.78% |
| 2020 Q3 | 78.53 Thousand CAD | 25.57% |
| 2020 Q4 | 92.22 Thousand CAD | 17.42% |
| 2020 Q2 | 62.54 Thousand CAD | -28.38% |
| 2019 Q2 | 55.26 Thousand CAD | -27.31% |
| 2019 Q3 | 101.39 Thousand CAD | 83.45% |
| 2019 Q4 | 213.36 Thousand CAD | 110.44% |
| 2019 FY | 213.36 Thousand CAD | 14.27% |
| 2019 Q1 | 76.03 Thousand CAD | -59.28% |
| 2018 Q2 | 47.11 Thousand CAD | -55.31% |
| 2018 Q1 | 105.41 Thousand CAD | -33.47% |
| 2018 Q4 | 186.71 Thousand CAD | 247.0% |
| 2018 FY | 186.71 Thousand CAD | 17.84% |
| 2018 Q3 | 53.8 Thousand CAD | 14.22% |
| 2017 FY | 158.45 Thousand CAD | 2895.39% |
| 2017 Q1 | 54.4 Thousand CAD | 928.45% |
| 2017 Q4 | 158.45 Thousand CAD | 321.58% |
| 2017 Q3 | 37.58 Thousand CAD | -57.97% |
| 2017 Q2 | 89.43 Thousand CAD | 64.38% |
| 2016 Q1 | 35.45 Thousand CAD | -49.05% |
| 2016 Q4 | 5290.00 CAD | -84.37% |
| 2016 FY | 5290.00 CAD | -92.4% |
| 2016 Q3 | 33.85 Thousand CAD | -9.89% |
| 2016 Q2 | 37.56 Thousand CAD | 5.96% |
| 2015 Q3 | 110.29 Thousand CAD | 12.83% |
| 2015 Q1 | 84.02 Thousand CAD | 2.86% |
| 2015 FY | 69.59 Thousand CAD | -14.81% |
| 2015 Q4 | 69.59 Thousand CAD | -36.9% |
| 2015 Q2 | 97.74 Thousand CAD | 16.33% |
| 2014 Q1 | 52.26 Thousand CAD | 48.27% |
| 2014 Q2 | 117.49 Thousand CAD | 124.8% |
| 2014 FY | 81.69 Thousand CAD | 131.74% |
| 2014 Q4 | 81.69 Thousand CAD | -8.72% |
| 2014 Q3 | 89.49 Thousand CAD | -23.83% |
| 2013 FY | 35.25 Thousand CAD | 1858.39% |
| 2013 Q4 | 35.25 Thousand CAD | 0.0% |
| 2012 FY | 1800.00 CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Zecotek Photonics Inc. | 5.86 Million USD | 95.774% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | 88.29% |
| Össur hf. | 688.8 Million USD | 99.964% |
| Wellstar International, Inc. | 55.99 Million USD | 99.557% |
| Össur hf. | 688.8 Million USD | 99.964% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | 95.875% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 98.458% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| QHSLab, Inc. | 2.05 Million USD | 87.943% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 99.459% |
| Vivos Inc. | 245 Thousand USD | -1.232% |
| Avitar, Inc. | 11.59 Million USD | 97.861% |
| Theraclion SA | 13.01 Million EUR | 98.095% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | 95.16% |
| Positron Corporation | 2.02 Million USD | 87.758% |
| ALR Technologies Inc. | 24.5 Million USD | 98.988% |
| Heart Tronics, Inc. | 1.09 Million USD | 77.345% |
| Nu-Med Plus, Inc. | 2.35 Million USD | 89.485% |
| BrainsWay Ltd. | 15.31 Million USD | 98.38% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.99% |
| BioElectronics Corporation | 16.62 Million USD | 98.508% |
| VMS Rehab Systems, Inc. | 201.36 USD | -123073.421% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 95.47% |
| AVITA Medical, Inc. | 19.86 Million USD | 98.751% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 99.622% |
| Escalon Medical Corp. | 2.94 Million USD | 91.588% |
| Aurora Spine Corporation | 6.65 Million USD | 96.272% |
| Odyssey Group International, Inc. | 6.61 Million USD | 96.249% |
| IR-Med Inc. | 634 Thousand USD | 60.88% |
| Kelyniam Global, Inc. | 1.01 Million USD | 75.515% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | 10.011% |
| United American Healthcare Corporation | 119 Thousand USD | -108.422% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | 89.876% |
| Nanomix Corporation | 14.81 Million USD | 98.326% |
| Stratec SE | 271.97 Million USD | 99.909% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | 93.151% |
| Lombard Medical, Inc. | 53.79 Million USD | 99.539% |
| Vycor Medical, Inc. | 4.31 Million USD | 94.256% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 95.471% |
| Ingen Technologies, Inc. | 5.7 Million USD | 95.656% |
| ECGI Holdings, Inc. | 11.94 Million USD | 97.923% |
| Capital Group Holdings, Inc. | 1.32 Million USD | 81.267% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | 82.852% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | 63.398% |
| Urologix, Inc. | 12.64 Million USD | 98.038% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 95.404% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 97.076% |
| SS Innovations International, Inc. | 11.18 Million USD | 97.782% |
| Polarean Imaging plc | 2.58 Million USD | 90.389% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | 52.793% |
| Smith & Nephew plc | 4.76 Billion USD | 99.995% |
| NIOX Group Plc | 9.8 Million USD | 97.47% |
| Fuse Medical, Inc. | 15.11 Million USD | 98.359% |
| Broncus Holding Corporation | 10.43 Million USD | 97.623% |
| Brain Scientific Inc. | 7.42 Million USD | 96.66% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 99.266% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | 68.766% |